Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma
Authors:
- 12 July 2021
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 26 (10) , 1890-1900
Abstract
Background Systemic inflammation has been correlated with worse survival for some cancers. We evaluated prognostic values of various inflammatory factor combinations in patients who underwent resections for hepatocellular carcinoma (HCC). Methods We retrospectively analysed 306 consecutive patients with HCC who underwent curative liver resections. After assessing eight combinations of inflammatory markers for predictive value for recurrence, we focused on lymphocyte-to-C-reactive protein ratio (LCR) to elucidate its associations with recurrence-free survival (RFS) and overall survival (OS) in univariate and multivariate analyses (Cox proportional hazards model). We also used immunohistochemical CD34 and CD8 staining to investigate the mechanism of LCR elevation. Results LCR showed the highest association with RFS in HCC patients among the compared indices. High preoperative LCR correlated with a high serum albumin concentration, small tumour size, early Barcelona Clinic Liver Cancer stage and low rates of microscopic vascular invasion and microscopic intrahepatic metastasis. Higher preoperative LCR was an independent predictor of longer RFS and OS in this cohort. High LCR patients had fewer vessels encapsulating tumour clusters, and higher intratumoural CD8+ T-cell counts than low LCR patients. Conclusions Preoperative LCR is a novel and convenient prognostic marker for patients with HCC, and is associated with the tumour microenvironment immune status.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP-19K09198)
This publication has 38 references indexed in Scilit:
- C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic PatientsPLOS ONE, 2013
- A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)British Journal of Cancer, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte‐predominantHodgkin lymphomaBritish Journal of Haematology, 2012
- Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysisSurgery Today, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Long-Term Results of Hepatic Resection Combined with Intraoperative Local Ablation Therapy for Patients with Multinodular Hepatocellular CarcinomasAnnals of Surgical Oncology, 2009
- Cancer-related inflammationNature, 2008
- Serum C‐reactive protein levels predict survival in hepatocellular carcinomaLiver International, 2007
- The impact of preoperative serum C‐reactive protein on the prognosis of patients with hepatocellular carcinomaCancer, 2005
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004